住友ファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/04/27 | 1,100 | 1,114 | 1,091 | 1,107 | -8 | -0.7% | 1,200,100 |
2022/04/26 | 1,099 | 1,128 | 1,096 | 1,115 | +16 | +1.5% | 1,165,600 |
2022/04/25 | 1,112 | 1,120 | 1,092 | 1,099 | -24 | -2.1% | 1,176,700 |
2022/04/22 | 1,119 | 1,130 | 1,110 | 1,123 | -14 | -1.2% | 1,194,900 |
2022/04/21 | 1,112 | 1,146 | 1,107 | 1,137 | +48 | +4.4% | 1,923,600 |
2022/04/20 | 1,095 | 1,110 | 1,078 | 1,089 | +1 | +0.1% | 1,939,200 |
2022/04/19 | 1,125 | 1,126 | 1,087 | 1,088 | -26 | -2.3% | 2,269,300 |
2022/04/18 | 1,170 | 1,171 | 1,102 | 1,114 | -60 | -5.1% | 2,043,200 |
2022/04/15 | 1,203 | 1,206 | 1,174 | 1,174 | -44 | -3.6% | 1,373,500 |
2022/04/14 | 1,198 | 1,232 | 1,194 | 1,218 | +30 | +2.5% | 1,391,700 |
2022/04/13 | 1,188 | 1,195 | 1,168 | 1,188 | -9 | -0.8% | 2,069,700 |
2022/04/12 | 1,234 | 1,248 | 1,195 | 1,197 | -53 | -4.2% | 1,194,100 |
2022/04/11 | 1,242 | 1,251 | 1,231 | 1,250 | +16 | +1.3% | 799,500 |
2022/04/08 | 1,243 | 1,256 | 1,225 | 1,234 | -9 | -0.7% | 1,112,000 |
2022/04/07 | 1,227 | 1,247 | 1,220 | 1,243 | -7 | -0.6% | 1,129,300 |
2022/04/06 | 1,237 | 1,261 | 1,237 | 1,250 | +8 | +0.6% | 957,200 |
2022/04/05 | 1,284 | 1,285 | 1,233 | 1,242 | -48 | -3.7% | 1,465,500 |
2022/04/04 | 1,262 | 1,298 | 1,251 | 1,290 | +49 | +3.9% | 1,361,500 |
2022/04/01 | 1,210 | 1,247 | 1,197 | 1,241 | +33 | +2.7% | 1,723,900 |
2022/03/31 | 1,230 | 1,235 | 1,208 | 1,208 | -34 | -2.7% | 1,496,300 |
2022/03/30 | 1,283 | 1,284 | 1,227 | 1,242 | -43 | -3.3% | 1,145,600 |
2022/03/29 | 1,285 | 1,289 | 1,271 | 1,285 | -1 | -0.1% | 651,100 |
2022/03/28 | 1,274 | 1,300 | 1,265 | 1,286 | +4 | +0.3% | 757,300 |
2022/03/25 | 1,276 | 1,284 | 1,258 | 1,282 | +18 | +1.4% | 838,700 |
2022/03/24 | 1,260 | 1,266 | 1,240 | 1,264 | -3 | -0.2% | 594,200 |
2022/03/23 | 1,275 | 1,277 | 1,259 | 1,267 | +4 | +0.3% | 818,400 |
2022/03/22 | 1,246 | 1,266 | 1,241 | 1,263 | +22 | +1.8% | 920,900 |
2022/03/18 | 1,255 | 1,258 | 1,219 | 1,241 | -9 | -0.7% | 1,013,800 |
2022/03/17 | 1,249 | 1,252 | 1,226 | 1,250 | +33 | +2.7% | 717,700 |
2022/03/16 | 1,204 | 1,222 | 1,203 | 1,217 | +9 | +0.7% | 790,900 |
2022/03/15 | 1,182 | 1,210 | 1,178 | 1,208 | +20 | +1.7% | 639,300 |
2022/03/14 | 1,174 | 1,211 | 1,174 | 1,188 | +16 | +1.4% | 743,200 |
2022/03/11 | 1,187 | 1,195 | 1,160 | 1,172 | -14 | -1.2% | 1,063,100 |
2022/03/10 | 1,165 | 1,191 | 1,154 | 1,186 | +49 | +4.3% | 1,241,600 |
2022/03/09 | 1,157 | 1,164 | 1,136 | 1,137 | -20 | -1.7% | 1,233,800 |
2022/03/08 | 1,180 | 1,193 | 1,155 | 1,157 | -23 | -1.9% | 1,383,900 |
2022/03/07 | 1,176 | 1,187 | 1,161 | 1,180 | -9 | -0.8% | 777,400 |
2022/03/04 | 1,227 | 1,236 | 1,184 | 1,189 | -52 | -4.2% | 1,358,500 |
2022/03/03 | 1,227 | 1,245 | 1,216 | 1,241 | +31 | +2.6% | 834,300 |
2022/03/02 | 1,234 | 1,239 | 1,206 | 1,210 | -30 | -2.4% | 979,600 |
2022/03/01 | 1,266 | 1,272 | 1,238 | 1,240 | -23 | -1.8% | 924,500 |
2022/02/28 | 1,226 | 1,269 | 1,226 | 1,263 | +32 | +2.6% | 1,091,400 |
2022/02/25 | 1,237 | 1,251 | 1,218 | 1,231 | -11 | -0.9% | 1,067,600 |
2022/02/24 | 1,230 | 1,252 | 1,228 | 1,242 | +10 | +0.8% | 1,073,400 |
2022/02/22 | 1,237 | 1,240 | 1,222 | 1,232 | -15 | -1.2% | 765,300 |
2022/02/21 | 1,269 | 1,269 | 1,238 | 1,247 | -45 | -3.5% | 842,700 |
2022/02/18 | 1,266 | 1,303 | 1,264 | 1,292 | +20 | +1.6% | 1,294,100 |
2022/02/17 | 1,273 | 1,282 | 1,257 | 1,272 | -4 | -0.3% | 898,500 |
2022/02/16 | 1,253 | 1,280 | 1,248 | 1,276 | +32 | +2.6% | 1,044,700 |
2022/02/15 | 1,241 | 1,257 | 1,235 | 1,244 | -1 | -0.1% | 1,086,800 |
751~
800
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「住友ファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
住友ファーマ | 78,300円 | -11.0% | +206.6% | 0.00% | 7.78倍 | 1.84倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ロート | 204,000円 | +8.4% | +0.2% | 2.06% | 14.83倍 | 1.78倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
久光薬 | 415,400円 | +5.8% | +1.2% | 2.89% | 13.78倍 | 1.10倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ツムラ | 349,600円 | +3.8% | -19.9% | 3.89% | 11.44倍 | 0.88倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
日本新薬 | 345,300円 | +8.0% | -15.3% | 3.59% | 9.69倍 | 0.94倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム